NVRO Insider Trading

Insider Ownership Percentage: 3.20%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Nevro Insider Trading History Chart

This chart shows the insider buying and selling history at Nevro by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$200k$0$200kTotal Insider BuyingTotal Insider Selling

Nevro Share Price & Price History

Current Price: $5.85
Price Change: Price Increase of +0.005 (0.09%)
As of 03/31/2025 04:59 PM ET

This chart shows the closing price history over time for NVRO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMar$5.84Closing price on 03/30/25:

Nevro Insider Trading History

See Full Table

SEC Filings (Institutional Ownership Changes) for Nevro (NYSE:NVRO)

95.52% of Nevro stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at NVRO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$10Mbought$10MsoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$500M$0$500MTotal InflowsTotal Outflows
Nevro logo
Nevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally. The company provides HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS implantable pulse generator (IPG) system, an evidence-based neuromodulation system for the treatment of chronic back and leg pain through paresthesia-free 10 kHz therapy, as well as offers Senza II and Senza Omnia SCS IPG systems. It also offers Senza HFX iQ platform, that includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system; and provides sacroiliac joint fusion devices under NevroV1, NevroFix, and NevroPro brands. In addition, the company offers surpass surgical and percutaneous leads. It sells its products through its direct sales force, and a network of sales agents and independent distributors. The company was incorporated in 2006 and is headquartered in Redwood City, California.
Read More on Nevro

Today's Range

Now: $5.85
Low: $5.83
High: $5.85

50 Day Range

MA: $5.56
Low: $4.57
High: $5.85

52 Week Range

Now: $5.85
Low: $3.17
High: $14.43

Volume

640,909 shs

Average Volume

736,277 shs

Market Capitalization

$224.28 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.94

Who are the company insiders with the largest holdings of Nevro?

Nevro's top insider investors include:
  1. Shawn Mccormick (Director)
Learn More about top insider investors at Nevro.

Who are the major institutional investors of Nevro?

Nevro's top institutional investors include:
  1. ArrowMark Colorado Holdings LLC — 11.64%
  2. D. E. Shaw & Co. Inc. — 4.81%
  3. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC — 2.49%
  4. Geode Capital Management LLC — 2.21%
  5. Assenagon Asset Management S.A. — 1.79%
  6. Jacobs Levy Equity Management Inc. — 1.77%
Learn More about top institutional investors of Nevro stock.

Which major investors are selling Nevro stock?

In the last quarter, NVRO stock was sold by these institutional investors:
  1. Western Standard LLC
  2. Assenagon Asset Management S.A.
  3. Federated Hermes Inc.
  4. Lazard Asset Management LLC
  5. Bank of America Corp DE
  6. Millennium Management LLC
  7. Wolverine Trading LLC
  8. Jacobs Levy Equity Management Inc.

Which major investors are buying Nevro stock?

During the last quarter, NVRO stock was acquired by institutional investors including:
  1. Cantor Fitzgerald L. P.
  2. D. E. Shaw & Co. Inc.
  3. Prudential Financial Inc.
  4. Susquehanna Fundamental Investments LLC
  5. MYDA Advisors LLC
  6. Raymond James Financial Inc.
  7. Raymond James Financial Inc.
  8. Two Sigma Investments LP